Cumberland Pharmaceuticals (CPIX) EPS (Weighted Average and Diluted) (2016 - 2025)
Cumberland Pharmaceuticals (CPIX) has disclosed EPS (Weighted Average and Diluted) for 16 consecutive years, with -$0.09 as the latest value for Q4 2025.
- Quarterly EPS (Weighted Average and Diluted) rose 35.71% to -$0.09 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$0.19 through Dec 2025, up 59.57% year-over-year, with the annual reading at -$0.19 for FY2025, 58.7% up from the prior year.
- EPS (Weighted Average and Diluted) hit -$0.09 in Q4 2025 for Cumberland Pharmaceuticals, up from -$0.13 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.08 in Q1 2025 to a low of -$0.44 in Q4 2023.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.09 across 5 years, with a median of -$0.08 in 2024.
- Biggest five-year swings in EPS (Weighted Average and Diluted): skyrocketed 166.67% in 2023 and later crashed 1500.0% in 2024.
- Year by year, EPS (Weighted Average and Diluted) stood at -$0.29 in 2021, then surged by 41.38% to -$0.17 in 2022, then plummeted by 158.82% to -$0.44 in 2023, then soared by 68.18% to -$0.14 in 2024, then surged by 35.71% to -$0.09 in 2025.
- Business Quant data shows EPS (Weighted Average and Diluted) for CPIX at -$0.09 in Q4 2025, -$0.13 in Q3 2025, and -$0.05 in Q2 2025.